We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
+10.3%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$3.7B
AUM Growth
+$254M
Cap. Flow
-$65M
Cap. Flow %
-1.76%
Top 10 Hldgs %
30.99%
Holding
194
New
8
Increased
30
Reduced
27
Closed
6

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$13.2M
2
SONY icon
Sony
SONY
+$1.09M
3
FRO icon
Frontline
FRO
+$741K
4
ORCL icon
Oracle
ORCL
+$550K
5
PHG icon
Philips
PHG
+$435K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$23.5M
2
CELG
Celgene Corp
CELG
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$14.7M
4
APD icon
Air Products & Chemicals
APD
+$13.5M
5
PH icon
Parker-Hannifin
PH
+$5.19M

Sector Composition

Rank Sector Weight
1 Technology 34.09%
2 Industrials 19.8%
3 Healthcare 19.73%
4 Consumer Staples 12.67%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$124B
$58.4M 1.58%
909,053
+230,789
+34% +$13.2M
ITW icon
27
Illinois Tool Works
ITW
$79.4B
$56.9M 1.54%
316,631
– –
INTC icon
28
Intel
INTC
$478B
$56M 1.52%
935,722
– –
UNP icon
29
Union Pacific
UNP
$179B
$55.2M 1.49%
305,512
– –
HON icon
30
Honeywell
HON
$71.3B
$54.3M 1.47%
325,786
+212
+0.1% +$34.7K
PPG icon
31
PPG Industries
PPG
$26.2B
$54.2M 1.47%
406,213
– –
MCHP icon
32
Microchip Technology
MCHP
$44B
$53.5M 1.45%
1,021,520
-7,000
-0.7% -$338K
KEYS icon
33
Keysight
KEYS
$54B
$51.4M 1.39%
501,179
– –
LOW icon
34
Lowe's Companies
LOW
$117B
$51.1M 1.38%
426,578
– –
CSL icon
35
Carlisle Companies
CSL
$14B
$50.4M 1.36%
311,200
-20,000
-6% -$3.08M
PFE icon
36
Pfizer
PFE
$143B
$46.7M 1.26%
1,255,856
+1,117
+0.1% +$39.8K
PH icon
37
Parker-Hannifin
PH
$120B
$46.2M 1.25%
224,562
-26,800
-11% -$5.19M
FAST icon
38
Fastenal
FAST
$52.2B
$44.5M 1.2%
2,409,016
– –
SAP icon
39
SAP
SAP
$186B
$44.3M 1.2%
330,442
– –
GPC icon
40
Genuine Parts
GPC
$17.2B
$41M 1.11%
386,365
– –
CLX icon
41
Clorox
CLX
$11.6B
$38.6M 1.04%
251,284
-100
-0% -$14.9K
ABT icon
42
Abbott
ABT
$175B
$37.3M 1.01%
429,025
– –
ORCL icon
43
Oracle
ORCL
$364B
$37.2M 1.01%
702,987
+10,000
+1% +$550K
CL icon
44
Colgate-Palmolive
CL
$74.4B
$37M 1%
537,666
– –
CNI icon
45
Canadian National Railway
CNI
$78.3B
$36M 0.97%
398,000
+400
+0.1% +$35.9K
LECO icon
46
Lincoln Electric
LECO
$13.8B
$34.9M 0.95%
361,200
– –
LIN icon
47
Linde
LIN
$237B
$34.5M 0.93%
161,871
+200
+0.1% +$40.3K
APD icon
48
Air Products & Chemicals
APD
$65.8B
$33.4M 0.9%
141,975
-60,000
-30% -$13.5M
ABBV icon
49
AbbVie
ABBV
$450B
$32.4M 0.88%
366,476
-4,000
-1% -$332K
KMB icon
50
Kimberly-Clark
KMB
$36B
$32.2M 0.87%
234,200
– –
1
2
3 4 5

Similar funds

FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.07B AUM 18.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return

Saturna Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Saturna Capital held 194 positions worth $3.7B, up 7.4% from $3.44B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Saturna Capital's Q4 2019 filing shows 8 new, 30 increased, 27 reduced and 6 closed positions. Its largest new stake was Sony: 87,500 shares worth $1.19M. The largest sale was Johnson & Johnson, an estimated $23.5M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Industrials and Healthcare.

  • Saturna Capital's largest Q4 2019 buy was Sony: 87,500 shares worth $1.19M.
  • Saturna Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $13.2M increase.
  • Saturna Capital's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $23.5M.
  • Saturna Capital fully exited Celgene Corp in Q4 2019, selling an estimated $20.4M.
  • Saturna Capital's ten largest holdings make up 31% of its $3.7B portfolio in Q4 2019.
  • Saturna Capital opened 8 new positions and closed 6 in Q4 2019.
  • Saturna Capital's portfolio value rose 7.4% quarter-over-quarter to $3.7B.

Based on Saturna Capital's 13F filing for Q4 2019, filed 13 Feb 2020.